8 research outputs found
cTNI-values in 3 patients with Fabry disease.
<p>cTNI-values in 3 patients with Fabry disease.</p
Baseline data, medical history, biomarkers and cardiac work up in patients with FD in relation to cardiac troponin I elevation and normal values.
<p>*a small fibre dysfunction was proved by quantitative sensory testing or by skin biopsy.</p>†<p>measurement end-diastolic in the posterior wall of the left ventricle.</p>$<p>Arrhythmia was considered if one of the following conditions was detected: persistent or intermittent atrial fibrillation of flatter, sustained tachycardia (heart rate ≥100/minute for more than 30 seconds), non-sustained tachycardia (heart rate ≥100/minute for less than 30 seconds in at least 3 subsequent hear cycles), incomplete bundle branch block (QRS-duration: 100–119 ms) or complete bundle branch block (QRS-duration ≥120 ms).</p>§<p>lower level of quantification.</p
Cardiac work up in patient 2.
<p>A+B: Coronary angiography (A: right coronary artery; B: left coronary artery) demonstrating no relevant pathology. C+D: Cardiac MRI showing increase in myocardial wall thickness (C) and pathological late gadolinium enhancement (D, arrow). E: Myocardial biopsy revealing strong accumulation of Gb<sub>3,</sub> as indicated by numerous vacuoles within the cardiomyocytes (arrow).</p
Synopsis of alpha-galactosidase gene mutations in 14 patients included in the study.
<p>Synopsis of alpha-galactosidase gene mutations in 14 patients included in the study.</p
Comparison of cardiac troponin I levels.
<p>Presented are patients with Fabry disease (FD) and left ventricular hypertrophy (LVH) (n = 17) versus FD patients without LVH (n = 18) and non-FD patients with LVH of other cause (n = 17). The cut-off level for cTnI in diagnosing myocardial infarction (≥0.04 ng/ml) is indicated in the figure.</p
Characteristics in 17 age- and sex-matched individuals with left ventricular hypertrophy due to hypertension.
<p>Characteristics in 17 age- and sex-matched individuals with left ventricular hypertrophy due to hypertension.</p
Patients with Fabry disease: comparison of patients with cTnI elevation ≥0.04 ng/ml versus without.
<p>Patients with Fabry disease: comparison of patients with cTnI elevation ≥0.04 ng/ml versus without.</p
Multiple logistic regression analysis for elevated cardiac troponin (cut-off ≥0.04 ng/ml) patients with Fabry disease (n = 62).
<p>Multiple logistic regression analysis for elevated cardiac troponin (cut-off ≥0.04 ng/ml) patients with Fabry disease (n = 62).</p